These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32566027)

  • 21. Detection of Promoter DNA Methylation in Urine and Plasma Aids the Detection of Non-Small Cell Lung Cancer.
    Liu B; Ricarte Filho J; Mallisetty A; Villani C; Kottorou A; Rodgers K; Chen C; Ito T; Holmes K; Gastala N; Valyi-Nagy K; David O; Gaba RC; Ascoli C; Pasquinelli M; Feldman LE; Massad MG; Wang TH; Jusue-Torres I; Benedetti E; Winn RA; Brock MV; Herman JG; Hulbert A
    Clin Cancer Res; 2020 Aug; 26(16):4339-4348. PubMed ID: 32430478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional identification of cancer-specific methylation of CDO1, HOXA9, and TAC1 for the diagnosis of lung cancer.
    Wrangle J; Machida EO; Danilova L; Hulbert A; Franco N; Zhang W; Glöckner SC; Tessema M; Van Neste L; Easwaran H; Schuebel KE; Licchesi J; Hooker CM; Ahuja N; Amano J; Belinsky SA; Baylin SB; Herman JG; Brock MV
    Clin Cancer Res; 2014 Apr; 20(7):1856-64. PubMed ID: 24486589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetic Status of CDO1 Gene May Reflect Chemosensitivity in Colon Cancer with Postoperative Adjuvant Chemotherapy.
    Yokoi K; Harada H; Yokota K; Ishii S; Tanaka T; Nishizawa N; Shimazu M; Kojo K; Miura H; Yamanashi T; Sato T; Nakamura T; Watanabe M; Yamashita K
    Ann Surg Oncol; 2019 Feb; 26(2):406-414. PubMed ID: 30311169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequent epigenetic inactivation of deleted in lung and esophageal cancer 1 gene by promoter methylation in non-small-cell lung cancer.
    Zhang Y; Miao Y; Yi J; Wang R; Chen L
    Clin Lung Cancer; 2010 Jul; 11(4):264-70. PubMed ID: 20630829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cysteine dioxygenase type 1 (CDO1) gene promoter methylation during the adenoma-carcinoma sequence in colorectal cancer.
    Kojima K; Nakamura T; Ohbu M; Katoh H; Ooizumi Y; Igarashi K; Ishii S; Tanaka T; Yokoi K; Nishizawa N; Yokota K; Kosaka Y; Sato T; Watanabe M; Yamashita K
    PLoS One; 2018; 13(5):e0194785. PubMed ID: 29746493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The Role of Plasma CDO1 Methylation in the Early Diagnosis of Lung Cancer].
    Wang P; Zhao H; Shi R; Liu X; Liu J; Ren F; Zhao Q; Zhang H; Li Y; Liu H; Chen J
    Zhongguo Fei Ai Za Zhi; 2020 May; 23(5):314-320. PubMed ID: 32317090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted demethylation of the CDO1 promoter based on CRISPR system inhibits the malignant potential of breast cancer cells.
    Yang J; Sun L; Liu XY; Huang C; Peng J; Zeng X; Zheng H; Cen W; Xu YX; Zhu W; Wu XY; Ling D; Zhang LL; Wei M; Liu Y; Wang D; Wang FH; Li YH; Li Q; Du Z
    Clin Transl Med; 2023 Sep; 13(9):e1423. PubMed ID: 37740473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of onset of remnant gastric cancer by promoter DNA methylation of
    Kojima K; Minatani N; Ushiku H; Ishii S; Tanaka T; Yokoi K; Nishizawa N; Ooizumi Y; Igarashi K; Hosoda K; Moriya H; Mieno H; Watanabe M; Yamashita K
    Oncotarget; 2019 Mar; 10(25):2423-2434. PubMed ID: 31069006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cysteine dioxygenase 1 is a metabolic liability for non-small cell lung cancer.
    Kang YP; Torrente L; Falzone A; Elkins CM; Liu M; Asara JM; Dibble CC; DeNicola GM
    Elife; 2019 May; 8():. PubMed ID: 31107239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of DLC-1 expression and methylation status in patients with non-small-cell lung cancer.
    Feng H; Zhang Z; Wang X; Liu D
    Mol Clin Oncol; 2016 Feb; 4(2):249-254. PubMed ID: 26893870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypermethylation of
    Ma H; Chen X; Hu H; Li B; Ying X; Zhou C; Zhong J; Zhao G; Duan S
    Oncol Lett; 2018 Jun; 15(6):9017-9024. PubMed ID: 29805634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of apoptosis-associated speck-like protein containing a CARD gene promoter methylation in resectable non-small-cell lung cancer.
    Zhang Z; Tan S; Zhang L
    Clin Lung Cancer; 2006 Jul; 8(1):62-5. PubMed ID: 16870048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FHIT promoter methylation status, low protein and high mRNA levels in patients with non-small cell lung cancer.
    Czarnecka KH; Migdalska-Sęk M; Domańska D; Pastuszak-Lewandoska D; Dutkowska A; Kordiak J; Nawrot E; Kiszałkiewicz J; Antczak A; Brzeziańska-Lasota E
    Int J Oncol; 2016 Sep; 49(3):1175-84. PubMed ID: 27572663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survival.
    Brabender J; Usadel H; Danenberg KD; Metzger R; Schneider PM; Lord RV; Wickramasinghe K; Lum CE; Park J; Salonga D; Singer J; Sidransky D; Hölscher AH; Meltzer SJ; Danenberg PV
    Oncogene; 2001 Jun; 20(27):3528-32. PubMed ID: 11429699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epigenomic profiling of non-small cell lung cancer xenografts uncover LRP12 DNA methylation as predictive biomarker for carboplatin resistance.
    Grasse S; Lienhard M; Frese S; Kerick M; Steinbach A; Grimm C; Hussong M; Rolff J; Becker M; Dreher F; Schirmer U; Boerno S; Ramisch A; Leschber G; Timmermann B; Grohé C; Lüders H; Vingron M; Fichtner I; Klein S; Odenthal M; Büttner R; Lehrach H; Sültmann H; Herwig R; Schweiger MR
    Genome Med; 2018 Jul; 10(1):55. PubMed ID: 30029672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The endometrial cancer detection using non-invasive hypermethylation of
    Cai B; Du J; Wang Y; Liu Z; Wang Y; Li L; Liu P; Wang L; Liu Q; Meng Z
    Cytojournal; 2024; 21():15. PubMed ID: 38841418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypermethylation of tumor necrosis factor decoy receptor gene in non-small cell lung cancer.
    Qi Y; Qi L; Qiu M; Yao C; Zhang M; Lin J; Zheng Z; Chen C; Li H; Duan S
    Oncol Lett; 2020 Jul; 20(1):155-164. PubMed ID: 32565943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Promoter methylation-mediated silencing of β-catenin enhances invasiveness of non-small cell lung cancer and predicts adverse prognosis.
    Miao Y; Wang L; Zhang X; Xu X; Jiang G; Fan C; Liu Y; Lin X; Yu J; Zhang Y; Wang E
    PLoS One; 2014; 9(11):e112258. PubMed ID: 25396757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic role of Wnt pathway gene promoter methylation in non small cell lung cancer.
    Liu S; Chen X; Chen R; Wang J; Zhu G; Jiang J; Wang H; Duan S; Huang J
    Oncotarget; 2017 May; 8(22):36354-36367. PubMed ID: 28422739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cysteine dioxygenase type 1 (CDO1): Its functional role in physiological and pathophysiological processes.
    Chen M; Zhu JY; Mu WJ; Guo L
    Genes Dis; 2023 May; 10(3):877-890. PubMed ID: 37396540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.